Ultrasound and Electric Field Stimulation to Treat Chronic Wounds
A Jerusalem-based medical device company developing and marketing innovative products for increasing blood flow and...
Nano-particles Distract Immune Cells to Reduce Inflammation
Most of us, no matter how many time-saving techniques we employ, don’t have enough time to waste. But...
ASCO Warns of Cancer Risks Associated with Alcohol Consumption
Moderate amounts - even as little as a glass of wine or beer a day -of alcohol consumption...
Merck Receives FDA Approval of its CMV drug Prevymis
The USFDA has now announced the approval of Merck’s Prevymis (letermovir) tablets and injection, the first...
Takeda’s dengue vaccine produces promising results in a trial
Takeda’s dengue candidate TAK-003 has now shown a high protective efficacy rate in the DEN-204 trial,...
Torrent Pharma All Set to Acquire Unichem Labs' India Business
Ahmadabad-based Flagship Company of the Torrent Group, Torrent Pharmaceuticals, has now announced that it will...
FDA Approves World's First Non-Magnetic MRI Monitor
Thinly traded micro cap iRadimed has now announced 510(k) clearance from the FDA for its 3880 MR-compatible patient...
Research Scholars Program - II - 2017 @ CDFD (Centre for DNA Fingerprinting and Diagnostics)
The CDFD (Centre for DNA Fingerprinting and Diagnostics), Hyderabad, is...
Bausch + Lomb and Nicox Announce FDA Approval of Vyzulta
Vizsla, the first prostaglandin analog with one of its metabolites being nitric oxide (NO), has...
NIH Handing Out 10,000 Fitbits to Gather Vital Health Data
Fitbit has been tussling with Apple and Xiaomi when it comes to market share in the wearables field and...
“Sugar-Glass” Wraps Use Viruses to Kill Bacteria and Preserve Your Food
Using viruses to kill bacteria. Alas, the irony!
With antibiotic resistance on the rise, bacterial...
Roche Veteran Comes Aboard Struggling GSK as Its New R&D Chief
GlaxoSmithKline has now confirmed the departure of President of R&D Patrick Vallance and announced...
NousCom Amasses €42M in Series B Funding Round
An oncology company developing neoantigen based cancer vaccines, NousCom, has now announced the completion of its €42m...
